Our Privacy Statement & Cookie Policy

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.

I agree

Astellas Pharma highlights China's advances in medicine approval and IP protection

03:13

Japanese pharmaceutical company Astellas has been in the Chinese market for 30 years. The company has focused on expanding Chinese patient access to its innovative pharmaceutical products and has strengthened partnerships with local companies.

Recently, CGTN's Wang Tianyu sat down with its chief commercial officer, Claus Zieler, to discuss pharmaceutical innovation and affordability in China's evolving pharmaceutical landscape.

Search Trends